Larotrectinib efficacy and safety in TRK fusion cancer: An expanded clinical dataset showing consistency in an age and tumor agnostic approach Meeting Abstract
| Authors: | Lassen, U. N.; Albert, C. M.; Kummar, S.; van Tilburg, C. M.; Dubois, S. G.; Geoerger, B.; Mascarenhas, L.; Federman, N.; Schilder, R. J.; Doz, F.; Berlin, J. D.; Oh, D. Y.; Bielack, S. S.; McDermott, R.; Tan, D. S.; Cruickshank, S.; Ku, N. C.; Cox, M. C.; Drilon, A.; Hong, D. S. |
| Abstract Title: | Larotrectinib efficacy and safety in TRK fusion cancer: An expanded clinical dataset showing consistency in an age and tumor agnostic approach |
| Meeting Title: | 43rd ESMO Congress (ESMO 2018) |
| Journal Title: | Annals of Oncology |
| Volume: | 29 |
| Issue: | Suppl. 8 |
| Meeting Dates: | 2018 Oct 19-23 |
| Meeting Location: | Munich, Germany |
| ISSN: | 0923-7534 |
| Publisher: | Oxford University Press |
| Date Published: | 2018-10-01 |
| Start Page: | mdy279.397 |
| Language: | English |
| ACCESSION: | WOS:000459277300400 |
| PROVIDER: | wos |
| DOI: | 10.1093/annonc/mdy279.397 |
| Notes: | Meeting Abstract: 409O -- Appears on page viii133 of the abstract book -- Source: Wos |
